Dr Bill Woods Atlanta, GA Death and Obituary – Dr. William G. “Bill” Woods, a distinguished leader in pediatric hematology and oncology, passed away on April 18, 2024, in Atlanta, Georgia, at the age of 77. His death marks the end of an era for pediatric cancer care, as he leaves behind an extraordinary legacy built on decades of groundbreaking research, clinical care, and leadership in the medical field.
Dr. Woods was born on October 11, 1946, in Baltimore, Maryland, where his passion for medicine began to take shape early in his life. He earned a Bachelor of Science in biology from Bucknell University in 1968, followed by a medical degree from the University of Pennsylvania in 1972. He continued his education through a pediatric residency at the University of Minnesota and a fellowship in pediatric hematology and oncology at Cornell University, laying the foundation for a career that would revolutionize the treatment of pediatric cancers.
Dr. Woods’ academic career began at the University of Minnesota in 1977, where he quickly became an integral part of the faculty. He made significant contributions to the field of pediatric oncology, particularly in hereditary retinoblastoma, neonatal screening for neuroblastoma, and acute myeloid leukemia (AML). One of his major achievements was leading a critical trial through the Children’s Cancer Group (CCG), which improved treatment protocols and survival rates for children with AML. His leadership extended beyond the clinic as he became involved in various national organizations, including the Children’s Oncology Group (COG), where he served on its executive committee and scientific council.
In 1996, Dr. Woods took on the role of Director of the South Carolina Cancer Center, where he continued his commitment to advancing pediatric cancer research and care. In 2001, he became the inaugural Director of the Aflac Cancer and Blood Disorders Center at Children’s Healthcare of Atlanta. Under his leadership, the center became one of the top pediatric oncology programs in the country. Dr. Woods’ impact was also felt at Emory University, where he served as Associate Director of the Winship Cancer Institute from 2001 to 2009. He played a pivotal role in expanding the faculty, enhancing research in bone marrow transplantation, sickle cell disease, and survivorship care.
Dr. Woods’ influence extended far beyond his direct work with patients. As President of the American Society of Pediatric Hematology/Oncology (ASPHO) in 2006, he led the organization through a strategic planning process that laid the foundation for improvements in care and funding for sickle cell anemia. He also initiated the Professional Development Committee and convened a summit to address long-term issues in pediatric oncology. Throughout his career, Dr. Woods authored more than 250 publications and garnered numerous accolades, including ASPHO’s Distinguished Career Award in 2011.
Perhaps one of his most defining traits was his humility and unwavering advocacy for patients. Colleagues and peers remember him not only for his scientific contributions but for his compassionate leadership style. His famous advice to “hire good people. Nice people. And let them do their best work” reflected his commitment to fostering an environment where others could thrive.
In his final years, Dr. Woods faced the challenge of amyotrophic lateral sclerosis (ALS) with the same courage that had defined his life’s work. He became a strong advocate for ALS research, working with organizations like the ALS Association and serving on the Clinical Trials Team for I AM ALS. He even participated in a phase 1 clinical trial, exemplifying his enduring commitment to advancing medical research.
Dr. Woods is survived by his wife, Kathleen, their sons, Elliot and Andrew, and four grandchildren. His legacy will live on in the countless patients he helped, the physicians he mentored, and the field of pediatric oncology that he helped shape. A memorial service will be held this summer to honor his life and accomplishments. Dr. Woods’ passing is a significant loss to the medical community, but his contributions will continue to impact the world for years to come.
